APA (7th ed.) Citation

AA, S., D, P., V, M., N, A., PM, R., AC, B., . . . CMP, R. (2026). miR-21-5p dysregulation is associated with gut microbiota dysbiosis and pro-oncogenic markers in primary sclerosing cholangitis with concomitant inflammatory bowel disease. Experimental and molecular pathology, 145, 105013. https://doi.org/10.1016/j.yexmp.2025.105013

Chicago Style (17th ed.) Citation

AA, Santos, et al. "MiR-21-5p Dysregulation Is Associated with Gut Microbiota Dysbiosis and Pro-oncogenic Markers in Primary Sclerosing Cholangitis with Concomitant Inflammatory Bowel Disease." Experimental and Molecular Pathology 145 (2026): 105013. https://doi.org/10.1016/j.yexmp.2025.105013.

MLA (9th ed.) Citation

AA, Santos, et al. "MiR-21-5p Dysregulation Is Associated with Gut Microbiota Dysbiosis and Pro-oncogenic Markers in Primary Sclerosing Cholangitis with Concomitant Inflammatory Bowel Disease." Experimental and Molecular Pathology, vol. 145, 2026, p. 105013, https://doi.org/10.1016/j.yexmp.2025.105013.